Opticon's catheter shows promise in pilot study:
This article was originally published in Clinica
Opticon Medical's valved urological catheter for the short-term management of urinary retention following lower urinary tract surgery has shown promising results in a pilot clinical study. The trial, which evaluated the Dublin, Ohio-based company catheter in 42 women, indicated that "a self-controlled valved catheter is feasible, safe and appreciated by patients," said study leader, Dr Rodney Appell of the Cleveland Clinic, Ohio. Dublin, Ohio Opticon plans to meet with the FDA in September to discuss the design of a multi-centre clinical trial of the device in the US.